Exploring how African genetic variations affect Alzheimer's disease risk
Interrogating the protective effect of African APOE alleles on Alzheimer's disease risk through pleiotropy
This study is looking at how certain genetic traits from African ancestry might affect the risk of developing Alzheimer's disease, specifically in African American and Caribbean communities, to help find ways to prevent the disease for those who might be at higher risk.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10980335 on NIH RePORTER |
What this research studies
This research investigates the relationship between specific African-derived genetic variations in the APOE gene and the risk of developing Alzheimer's disease (AD). By analyzing genetic data from African American and Caribbean populations, the study aims to identify which genetic variants contribute to a lower risk of AD. The researchers will also explore how these genetic factors influence biological processes related to AD, such as lipid metabolism and inflammation. This work could provide insights into the genetic basis of AD and help tailor prevention strategies for at-risk populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals of African descent, particularly those with a family history of Alzheimer's disease.
Not a fit: Patients who do not have African ancestry or those without a family history of Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and prevention strategies for Alzheimer's disease in African and African American populations.
How similar studies have performed: Previous research has shown promising results in understanding the genetic factors influencing Alzheimer's disease risk in diverse populations, suggesting that this approach could yield valuable insights.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Blue, Elizabeth Eloyce — University of Washington
- Study coordinator: Blue, Elizabeth Eloyce
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.